Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents
暂无分享，去创建一个
M. Konopleva | H. Kantarjian | G. Garcia-Manero | T. Kadia | F. Ravandi | Koichi Takahashi | G. Borthakur | E. Jabbour | N. Daver | C. Dinardo | N. Pemmaraju | N. Short | Y. Alvarado | M. Ohanian | D. Hammond | K. Sasaki | A. Maiti | G. Montalban-Bravo | Curtis A. Lachowiez | G. Issa | S. Pierce | Sa A Wang | Sanam Loghavi